Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
impacting heart function. Your Profile Scientific Background PhD in biomedical sciences with a strong emphasis on genome editing techniques. Hands-on experience with CRISPR-Cas9/CRISPR interference
-
Great Falls College Montana State University | Great Falls, Montana | United States | about 5 hours ago
, flexible start date. Quick Link for Internal Postings https://jobs.gfcmsu.edu/postings/1830 Notices Great Falls College Montana State University is committed to providing a working and learning environment
-
at the intersection of academia and practice. For more information on D^3, please visit https://d3.harvard.edu/labs . D^3 is looking for candidates with diverse backgrounds and/or new perspectives. There are no
-
this link to learn more, https://www.hopkinsmedicine.org/wilmer/education/clinical-training/ophthalmic_technician.html Specific Duties & Responsibilities Records patient history including chief complaint
-
the item in question will not interfere with job performance and where the employee is otherwise qualified. The University of Michigan agrees to abide by the protections afforded employees with disabilities
-
a two-year Global Patient Safety and Risk Management fellowship, based in Cambridge, MA. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a
-
Affairs fellowship, based in Cambridge, MA. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with
-
Global Medical Affairs TTR fellowship, based in Cambridge, MA. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative
-
Affairs fellowship, based in Cambridge, MA. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with
-
a two-year Global Medical Affairs Early Assets fellowship, based in Cambridge, MA. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole